Drug exposure and flow cytometry analyses in a thalidomide treatment schedule that prolongs rat cardiac graft survival.
Eriksson
T
T
Department of Surgery, Lund University, Malmö General Hospital, Sweden.
Riesbeck
K
K
Ostraat
O
O
Ekberg
H
H
Björkman
S
S
D000284:Administration, Oral; D000818:Animals; D016516:CD4-CD8 Ratio; D004334:Drug Administration Schedule; D005434:Flow Cytometry; D006084:Graft Rejection / Q000276:immunology; D006085:Graft Survival / Q000187:drug effects* / Q000276:immunology; D016027:Heart Transplantation / Q000276:immunology*; D016130:Immunophenotyping; D051381:Rats; D011920:Rats, Inbred WF; D016176:T-Lymphocyte Subsets / Q000187:drug effects / Q000276:immunology; D013792:Thalidomide / Q000493:pharmacokinetics / Q000494:pharmacology*
D013792:Thalidomide